全文获取类型
收费全文 | 1318篇 |
免费 | 61篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 37篇 |
妇产科学 | 22篇 |
基础医学 | 142篇 |
口腔科学 | 22篇 |
临床医学 | 183篇 |
内科学 | 358篇 |
皮肤病学 | 32篇 |
神经病学 | 132篇 |
特种医学 | 145篇 |
外科学 | 97篇 |
综合类 | 25篇 |
预防医学 | 67篇 |
眼科学 | 5篇 |
药学 | 67篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 5篇 |
2022年 | 7篇 |
2021年 | 7篇 |
2020年 | 5篇 |
2019年 | 11篇 |
2018年 | 15篇 |
2017年 | 12篇 |
2016年 | 13篇 |
2015年 | 20篇 |
2014年 | 22篇 |
2013年 | 31篇 |
2012年 | 38篇 |
2011年 | 47篇 |
2010年 | 44篇 |
2009年 | 45篇 |
2008年 | 43篇 |
2007年 | 53篇 |
2006年 | 57篇 |
2005年 | 65篇 |
2004年 | 49篇 |
2003年 | 51篇 |
2002年 | 49篇 |
2001年 | 42篇 |
2000年 | 49篇 |
1999年 | 35篇 |
1998年 | 47篇 |
1997年 | 52篇 |
1996年 | 48篇 |
1995年 | 29篇 |
1994年 | 38篇 |
1993年 | 26篇 |
1992年 | 24篇 |
1991年 | 22篇 |
1990年 | 27篇 |
1989年 | 37篇 |
1988年 | 39篇 |
1987年 | 29篇 |
1986年 | 16篇 |
1985年 | 17篇 |
1984年 | 23篇 |
1983年 | 18篇 |
1982年 | 15篇 |
1981年 | 15篇 |
1980年 | 7篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1969年 | 4篇 |
1965年 | 2篇 |
排序方式: 共有1384条查询结果,搜索用时 15 毫秒
91.
92.
The leptin receptor (OB-R) gene is a promising candidate gene for type 2 diabetes, because leptin and its receptor play an important role in insulin secretion and the development of obesity. Therefore, we studied whether the pentanucleotide insertion polymorphism of the 3'-untranslated region (3'UTR) of the OB-R gene has an influence on the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in the STOP-Noninsulin-Dependent Diabetes Mellitus trial. The STOP trial was a longitudinal, double-blind, placebo-controlled randomized trial that included 1429 subjects with IGT from high-risk populations. Using the restriction fragment length polymorphism method, we genotyped 770 subjects whose DNA was available for the insertion/deletion polymorphism of the 3'UTR of the OB-R gene. We did not find a relationship between the OB-R polymorphism and the conversion from IGT to type 2 diabetes (p = 0.747). However, the insertion allele was associated with a significant reduction in weight (p = 0.016), BMI (p = 0.009), and waist circumference (p = 0.006) in all subjects. Women carrying the I allele had a larger waist circumference change (p = 0.036), whereas men lost more weight and had a greater decrease in BMI. The pentanucleotide insertion/deletion polymorphism in the 3'UTR of the OB-R gene did not influence the conversion to type 2 diabetes in obese patients with IGT. However, this polymorphism was associated with a significant weight change, suggesting that it may potentially modulate the risk for type 2 diabetes. 相似文献
93.
Adiponectin is an adipose tissue-specific protein with insulin-sensitizing and antiatherogenic properties. Therefore, the adiponectin gene is a promising candidate gene for type 2 diabetes. We investigated the single nucleotide polymorphisms (SNPs) +45T/G and +276G/T of the adiponectin gene as predictors for the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial, which aimed to investigate the effect of acarbose compared with placebo on the prevention of type 2 diabetes. Compared with the TT genotype, the G-allele of SNP +45 was associated with a 1.8-fold risk for type 2 diabetes (95% CI 1.12-3.00, P = 0.015) in the placebo group. Subjects treated with placebo and simultaneously having the G-allele of SNP +45 and the T-allele of SNP +276 (the risk genotype combination) had a 4.5-fold (1.78-11.3, P = 0.001) higher risk of developing type 2 diabetes compared with subjects carrying neither of these alleles. Women carrying the risk genotype combination had an especially high risk of conversion to diabetes (odds ratio 22.2, 95% CI 2.7-183.3, P = 0.004). In conclusion, the G-allele of SNP +45 is a predictor for the conversion to type 2 diabetes. Furthermore, the combined effect of SNP +45 and SNP +276 on the development of type 2 diabetes was stronger than that of each SNP alone. 相似文献
94.
95.
Bresciani L Rossi R Testa C Geroldi C Galluzzi S Laakso MP Beltramello A Soininen H Frisoni GB 《Aging clinical and experimental research》2005,17(1):8-13
BACKGROUND AND AIMS: To test the agreement of a visual rating scale of medial temporal lobe atrophy (MTA) with linear and volumetric assessments, and to test its accuracy in discriminating between Alzheimer's disease (AD) patients and controls. METHODS: Participants were 28 patients with AD and 29 healthy controls. MTA was evaluated according to Scheltens' five-point scale. Its accuracy in distinguishing AD patients from controls was evaluated as a stand-alone measure and in association with linear [width of the temporal horn (WTH)] and volumetric [hippocampal volume (HV)] measures. RESULTS: The agreement of this visual rating scale with the other MTA measures was statistically significant (vs WTH and vs HV, p for trend < 0.00005). The visual rating scale showed a good accuracy in distinguishing AD patients from controls [area under the curve (AUC) 0.89, 95% confidence interval (CI) 0.79-0.98]. Although the accuracy of the visual rating scale improved in association with linear WTH (AUC 0.91, 95% CI 0.82-0.99) and in association with HV (AUC 0.93, 95% CI 0.86-1.00), the improvement was not significant. CONCLUSIONS: The visual rating scale of MTA, easily applicable in clinical practice, shows good agreement with more demanding quantitative methods, and can discriminate AD patients from controls with good accuracy. 相似文献
96.
A voxel based morphometry study on mild cognitive impairment 总被引:10,自引:0,他引:10
Pennanen C Testa C Laakso MP Hallikainen M Helkala EL Hänninen T Kivipelto M Könönen M Nissinen A Tervo S Vanhanen M Vanninen R Frisoni GB Soininen H 《Journal of neurology, neurosurgery, and psychiatry》2005,76(1):11-14
BACKGROUND: Mild cognitive impairment (MCI) is the most widely used concept in classifying cognitive impairment in the elderly who do not fulfil the criteria for dementia. MCI is considered to confer an increased risk of progressing to dementia and most often Alzheimer's disease (AD). Various approaches such as imaging of the brain have been applied to predict the conversion of MCI to dementia. A number of volumetric magnetic resonance imaging (MRI) studies have detected atrophy of the medial temporal lobe in subjects with MCI, but for the other cerebral regions the results have been inconsistent. OBJECTIVE: To study the pattern of brain atrophy in MCI. METHODS: Thirty two controls and 51 individuals with MCI deriving from population based cohorts were studied by MRI using voxel based morphometry. The threshold of t maps was set at p < 0.001. RESULTS: Individuals with MCI had significant unilateral atrophy in the medial temporal lobe on the right side. Less extensive atrophy was found elsewhere-for example, in the temporal lobe, left superior parietal lobule, left anterior cingulate gyrus, and bilaterally in the thalami. CONCLUSIONS: The MRI findings in MCI resemble those seen in early AD. 相似文献
97.
Dormandy JA Charbonnel B Eckland DJ Erdmann E Massi-Benedetti M Moules IK Skene AM Tan MH Lefèbvre PJ Murray GD Standl E Wilcox RG Wilhelmsen L Betteridge J Birkeland K Golay A Heine RJ Korányi L Laakso M Mokán M Norkus A Pirags V Podar T Scheen A Scherbaum W Schernthaner G Schmitz O Skrha J Smith U Taton J;PROactive investigators 《Lancet》2005,366(9493):1279-1289
98.
Häkkinen ST Rischer H Laakso I Maaheimo H Seppänen-Laakso T Oksman-Caldentey KM 《Planta medica》2004,70(10):936-941
Anatalline [2,4-di(3-pyridyl)piperidine] accumulation was shown to be induced by methyl jasmonate in Nicotiana tabacum cv. BY-2 cell cultures. Beside anatabine, anatalline represented the most abundant alkaloid, moreover, it was always present in two isomeric forms occurring always in similar concentrations. Both isomers could be completely separated by GC-MS. For structural analysis, the isolation of both isomers was performed using a semi-preparative HPLC system. The structures of anatalline [cis-2,4-di(3-pyridyl)piperidine] and its stereoisomer trans-2,4-di(3-pyridyl)piperidine were confirmed by MS and 1D and 2D NMR spectral data. The biosynthetic origin of anatalline was studied by feeding alkaloid precursors to BY-2 cell cultures. 相似文献
99.
Kärkkäinen S Peuhkurinen K Jääskeläinen P Miettinen R Kärkkäinen P Kuusisto J Laakso M 《American heart journal》2002,143(6):11-14
Background Dilated and hypertrophic cardiomyopathies are primary myocardial diseases that cause considerable morbidity and mortality. Although these cardiomyopathies are clinically heterogeneous, genetic factors play an important role in their etiology and pathogenesis. The defects in the cardiac actin (ACTC) gene can cause both cardiomyopathies. The aim of our study was to screen for variants in the ACTC gene in patients with dilated or hypertrophic cardiomyopathy from Eastern Finland. Materials and Methods Altogether, 32 patients with dilated and 40 patients with hypertrophic cardiomyopathy were included in the study. Commonly approved diagnostic criteria were applied, and secondary cardiomyopathies were carefully excluded. All 6 exons of the ACTC gene were amplified with polymerase chain reaction and screened for variants with single-strand conformation polymorphism analysis. Results and Conclusion We did not find any new or previously reported variants. Our results indicate that defects in the ACTC gene do not explain dilated cardiomyopathy or hypertrophic cardiomyopathy in subjects from Eastern Finland and confirm earlier results that the ACTC gene does not play an important role in the genetics of dilated or hypertrophic cardiomyopathies. (Am Heart J 2002;143:11-4.) 相似文献
100.
Päivä H Laakso J Lehtimäki T Isomustajärvi M Ruokonen I Laaksonen R 《Journal of cardiovascular pharmacology》2003,41(2):219-222
Asymmetric dimethylarginine (ADMA) and monomethylarginine (LMMA) are endogenous inhibitors of nitric oxide synthase. A high level of ADMA in plasma has shown to be a significant risk factor for acute coronary syndromes and elevated plasma ADMA levels are prevalent in patients with hypercholesterolemia. It was therefore hypothesized that lowering plasma cholesterol levels with statin treatment would also lower ADMA concentrations. This double-blind study addressed the effect of high-dose statin treatment on plasma levels of ADMA and LMMA. Forty-eight subjects with mild hypercholesterolemia were randomly assigned to receive simvastatin 80 mg/d, atorvastatin 40 mg/d, or placebo for 8 weeks. Both statins decreased low-density lipoprotein cholesterol effectively (simvastatin 54% and atorvastatin 49%). However, concentrations of arginine derivatives remained unchanged during statin treatment and did not correlate with cholesterol levels. This study indicates that statin treatment has no clear influence on plasma ADMA or LMMA concentrations. 相似文献